Alembic Pharmaceuticals gets USFDA final approval for Formoterol Fumarate Inhalation Solution

Alembic

Alembic Pharmaceuticals gets USFDA final approval for Formoterol Fumarate Inhalation Solution

Alembic Pharmaceuticals today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Formoterol Fumarate Inhalation Solution, 20 mcg/2 ml per Unit-Dose Vial.

At 11:53 hrs Alembic Pharmaceuticals was quoting at Rs 744.50, up Rs 8.85, or 1.20 percent on the BSE.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from bigprofitbuzz.com.

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button